News | August 20, 2014

UC San Diego Health System Utilizes ClearPoint System to Conduct Three Back-to-Back Procedures on a Single Patient

August 20, 2014 — MRI Interventions Inc. announced that neurosurgeons at UC San Diego Health System have utilized the ClearPoint system's platform capabilities to facilitate three same-setting MRI (magnetic resonance imaging)-guided neurosurgical procedures for a single patient. The team, led by Clark C. Chen, M.D., Ph.D., vice chairman of academic affairs for the division of neurosurgery at UC San Diego School of Medicine, biopsied a patient's brain tumor, aspirated a fluid-filled section of the tumor and ablated the tumor, all under real-time MRI guidance enabled by the ClearPoint system in the hospital's diagnostic MRI suite.

Utilizing conventional techniques, the three surgeries likely would have been split between two or three different settings and required the patient to be moved between the neuro OR and diagnostic MRI suite. The ClearPoint system, however, enables placement of multiple devices along the same trajectory, as well as facilitates intraoperative adjustments with real-time visual verification to accommodate multiple trajectories as necessary, all within a hospital's standard diagnostic MRI scanner.

MRI Interventions business development manager and clinical engineer Geoffrey Bates attended the surgery. "We were very happy to see the ClearPoint system's platform capabilities being utilized in a single case," said Bates. "UC San Diego took a set of procedures that would ordinarily be performed over multiple days and multiple rooms and condensed them into the same setting. That means fewer hospital visits for the patient and more efficient scheduling and workflow for the surgical team."

Using the ClearPoint system for the biopsy, Chen was able to see and select the tumor at its location within the brain, establish the desired trajectory to the tumor with MRI Interventions' SmartFrame targeting device and visualize the biopsy needle as it was inserted into the desired region of the tumor, confirming with real-time MRI that the sample was removed from the targeted location. Next, Chen was able to adjust the trajectory in order to aspirate a fluid-filled section of the tumor, monitoring the tumor's changing size and shape under MRI guidance as the fluid was removed. He then utilized the ClearPoint system to target the reduced tumor, visualize the placement of a laser catheter as he inserted it into the tumor and confirm placement of the catheter at the desired location for ablation. Finally, when intraprocedural MRI showed a portion of the tumor was irregularly shaped, he was able to once more adjust the SmartFrame targeting device to reposition the catheter so that he could ablate the final segment of the tumor.

The ClearPoint system is the only technology to enable minimally invasive neurosurgery under continuous MRI guidance. In addition to brain biopsy and the placement of shunts and laser ablation catheters, the ClearPoint system is also being utilized to place electrodes in the brain.

For more information: www.mriinterventions.com

Related Content

Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Siemens Healthineers Debuts Magnetom Altea 1.5T MRI Scanner
Technology | Magnetic Resonance Imaging (MRI) | December 06, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
Vital Showcases Enterprise Imaging Advances at RSNA 2018

Global Illumination from Vital Images

News | Enterprise Imaging | November 28, 2018
Vital, a Canon Group company, will highlight the latest additions to its enterprise imaging portfolio at the 2018...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...